Morphine-induced alterations in antibody levels: Receptor and immune mechanisms

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 2, 1996, Pages 689-696

  Lockwood, L L ^a   Silbert, L H ^b   Fleshner, M R ^b   McNeal, C ^b   Watkins, L R ^b   Laudenslager, M L ^c   Rice, K C ^d   Weber, R J ^e   Maier, S F ^b  

^a METROPOLITAN STATE UNIVERSITY OF DENVER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; MORPHINE; MORPHINE SULFATE;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; INTERFERON PRODUCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; STEREOCHEMISTRY;

ANIMALS; BINDING SITES; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNITY; IMMUNOGLOBULIN G; MALE; MORPHINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0030426721     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. ARORA, P. K., FRIDE, E., PETTITO, J., WAGGIE K. AND SKOLNICK, P.: Morphine-induced immune alterations in vivo. Cell. Immun. 126: 1-11, 1990.
2. BAND, L. C., PERT, A., WILLIAMS, W., DE COSTA, B. R., RICE, K. C. AND WEBER, R. J.: Central mu opioid receptors mediate suppression of natural killer activity in vivo. Progr. Neuro. Endocrin. Immunol. 5: 95-101, 1992.
3. BAND, L. C., PERT, A., WILLIAMS, W., SEGGEL, M., DE COSTA, B. R., RICE, K. C. AND WEBER, R. J.: Delineation of central opioid receptors regulating natural killer cell activity in vivo. Natl. Inst. Drug Abuse Res. Monogr. Series 119: 330, 1991.
4. BAYER, B. M. AND FLORES, C. M.: Effects of morphine on lymphocyte function: Possible mechanisms of interaction. In Drugs of Abuse and Immune Function, pp. 31-40, ed. by R. R. Watson, Boca Raton, FL, CRC Press, 1990.
5. BAYER, B. M., DAUSSIN, S., HERNANDEZ, M. AND IRWIN, L.: Morphine inhibition of lymphocyte activation is mediated by an opioid mechanism. Neuropharmacology 29: 369-374, 1990.
6. BESEDOVSKY, H. O., DEL REY, A., SORKIN, E., DA PRADA, M. AND KELLER, H. H.: Immunoregulation mediated by the sympathetic nervous system. Cell. Immunol. 48: 346-355, 1979.
7. BRYANT, H. U., BERNTON, E. W. AND HOLADAY, J. W.: Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 41: 1731-1738, 1987.
8. BRYANT, H. U., ROUDEBUSH, R. E.: Suppressive effects of morphine peleet implants on in vivo parameters of immune function. J. Pharmacol. Exp. Ther. 255: 410-414, 1990.
9. BRYANT, H. U., YOBURN, B. C., INTURRISI, C. E., BERNTON, E. W. AND HOLADAY, J. W.: Morphine-induced immunomodulation is not related to serum morphine concentrations. Eur. J. Pharmacol. 149: 165-169, 1988.
10. BUSSIERE, J. L., ADLER, M. W., ROGERS, T. J. AND EINSTEIN, T. K.: Differential effects of morphine and naltrexone on the antibody response in various mouse strains. Immunopharmacol. immunotoxicol. 14: 657-673, 1992.
11. CARR, D. J. J. AND KLIMPEL, G. R.: Enhancement of the generation of cytotoxic T cells by endogenous opiates. J. Neuroimmunol. 12: 57, 1986.
12. CARR, J. J., GEBHARDT, B. M. AND PAUL, D.: Alpha adrenergic and Mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J. Pharmacol. Exp. Ther. 264: 1179-1186, 1993.
13. 5-enkephalin in conscious rats. Arch. Int. Pharmacodynamics 265: 244-258, 1983.
14. CONWAY, E. L., BROWN, M. J. AND DOLLERY, C. T.: Studies on the pharmacology of central opioid-induced increases in plasma catecholamines in conscious rats. Neuropharmacology 23: 1291-1296, 1984.
15. COUSSONS-READ, M. E., DYKSTRA, L. A. AND LYSLE, D. T.: Pavlovian conditions of morphine-induced alterations of immune status: Evidence for opoid reexeptor involvement. J. Neuroimmunol. 55: 135-142, 1994.
16. COUTELIER, J. P., VAN DER LOGT, J. T. M., HEESEN, F. W. A., VINK, A. AND VAN SNICK J.: Virally induced modulation of muring IgG antibody subclasses. J. Exp. Med. 168: 2373-2378, 1988.
17. COUTELIER, J. P., VAN DER LOGT, J. T. M., HEESEN, F. W. A., WARNER, G. AND VAN SNICK J.: IgG2a restriction of murine antibody elicited by viral infections. J. Exp. Med. 165: 64-69, 1987.
18. DESAVIGNY, D. AND VOLLER, A.: The communication of ELISA data from laboratory to clinician. J. Immunol. 1: 105-128, 1980.
19. ESSER C. AND RADBRUCH, A.: Immunoglobulin class switching: Molecular and cellular analysis. Annu. Rev. Immunol. 8: 717-735, 1990.
20. FECHO, K., DYKSTRA, L. A. AND LYSLE, D. T.: Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. J. Pharmacol. Exp. Ther. 265: 1079-1087 1993.
21. FELTEN, D. L., FELTEN, S. Y., CARSON, S. L., OLSCHOWKA, J. A. AND LIVNAT, S.: Sympathetic neural interactions with the immune system. J. Immunol. 135: 755s-765s, 1985.
22. FINKELMAN, F. D., HOLMES, J., KATONA, I. M., URBAN, J. F., BECKMAN, M. P., PARK, L. S., SCHOOLEY, K. A., COFFMAN, R. L., MOSMANN, T. R. AND PAUL, W. E.: Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8: 303-333, 1990.
23. GUNGOR, M., GENC, E., SAGDUYU, H. EROGLU, L. AND KOYUNCOUGLU, J. H.: Effect of chronic administration of morphine on primary immune response in mice. Experientia 36: 1309-1310, 1980.
24. HALL, N. R., O'GRADY, M. P. AND MENZIES, R. A.: Neuroimmunopharmacologic effects of drugs of abuse. Adv. Exp. Med. Biol. 288: 13-23, 1991.
25. HERNANDEZ, M. C., FLORES, L. R. AND BAYER, B. M.: Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther. 267: 1336-1341, 1993.
26. HO, W. AND LEUNG, A.: The effect of morphine addiction on concanavalin A-mediated blastogenesis. Pharmacol. Res. Commun. 11: 413-419, 1979.
27. KIMES, A. S., SMITH, W. J., WINCHELL, C. J., LONDON, E. D.: Effects of morphine on the phenotypic expression of cell surface markers on muring lymphocytes. Life Sci. 51: 807-815, 1992.
28. KIAUS, G. G. B., PEPYS, M. B., KETAJIMA, K. AND ASKONAS, B. A.: Activation of mouse complement by different classes of mouse antibody. Immunology 38: 687-695, 1979.
29. KUBY, J.: Immunology. New York, W. H. Freeman and Co., 1992.
30. LAUDENSLAGER, M. L., FLESHNER, M., HOFSTADTER, P., HELD, P. E., SIMONS, L. AND MAIER, S. F.: Suppression of specific antibody production by inescapable shock: Stability under varying conditions. Brain, Behav. Immun. 2: 92-101, 1988.
31. LIEBESKIND, J. C.: Pain can kill. Pain 44: 3-4, 1991.
32. LOCKWOOD, L. L., SILBERT, L. H., FLESHNER, M., LAUDENSLAGER, M. L., WATKINS, L. R. AND MAIER, S. F.: Morphine-induced decreases in in vivo antibody responses. Brain Behav. Immun. 8: 24-36, 1994.
33. LOCKWOOD, L. L., SILBERT, L. H., LAUDENSLAGER, M. L., WATKINS, L. R. AND MAIER, S. F.: Anesthesia-induced changes in antibody levels. Anesthesia Analgesia 77: 769-774, 1993.
34. LYSLE, D. T., COUSSONS, M. E., WATTS, V. J., BENNETT, E. H. AND DYKSTRA, L. A.: Morphine-induced alterations in immune status: Dose dependency, compartment specificity, and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265: 1071-1078, 1993.
35. PASTERNAK, G. W.: The Opiate Receptors. Humana Press, Clifton, NJ, 1988.
36. PAUL, W.: Fundamental Immunology. New York, Raven Press, 1993.
37. PELLIS, N. R., HARPER, C. AND DAFNY, N.: Suppression of the induction of delayed hypersensitivity in rats by repetitive morphine treatments. Exp. Neurol. 93: 92, 1986.
38. PETERSON, P. K. SHARP, B., GEKKER, G., BRUMMITT, C. AND KEANE, W. F.: Opioid mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J. Clin. Invest. 80: 824-831, 1987.
39. PETERSON, P. K., GEKKER, G., HU, S., ANDERSON, W. R., KRAVITZ, F., PORTOGHESE, P. S., BALFOUR, H. H. AND CHAO, C. C.: Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J. Neuroimmunol. 50: 167-175, 1994.
40. PLAMONDEN, C., KOTTIS, V., BRIDEAUS, C., METROZDAYER, M. AND POUSSIER, P.: Abnormal thymocyte maturation in spontaneously diabetic BB rats involves the deletion of CD4-8+ cells. J. Immunol. 144: 923-928, 1990.
41. PRUETT, S. B., HAN Y. C. AND FUCHS, B. A.: Morphine suppresses primary humoral immune responses by a predominantly indirect mechanism. J. Pharmacol. Exp. Ther. 262: 923-928 1992.
42. RABIN, B. S., KUSNECOV, A., SHURIN, M., ZHOU, D. AND RASNICK, S.: Mechanistic aspects of stressor-induced immune alteration. In Handbook of Human Stress and Immunity, ed. by J. Kiecolt-Glaser, pp. 32-52, Academic Press, New York, 1994.
43. SHAVIT, Y., LEWIS J. W., TERMAN, G., GALE, R. P. AND LIEBESKIND J. C.: Opioid peptides mediate the suppressive effects of stress on NK cell cytotoxicity. Science 223: 188-190, 1984.
44. SHAVIT, Y., MARTIN, F. C., YIRMIYA, R., BEN-ELIYAHU, S., TERMAN, G. W., WEINER, H., GALE, R. P. AND LIEBESKIND, J. C.: Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity. Brain Behav. Immun, 1: 318-328, 1987.
45. SHAVIT, Y., TERMAN, G. W., LEWIS, J. W., ZANE, C. J., GALE, R. P. AND LIEBESKIND, J. C.: Effects of footshock stress and morphine on natural killer lymphocytes in rats: Studies of tolerance and cross tolerance. Brain Res. 372: 382, 1986.
46. STOELTING, R. K.: Current views on the role of opioid receptors and endorphins in anesthesiology. Int. Anesthesiol. Clin. 24: 17-27, 1986.
47. TAUB, D. D., EISENSTEIN, T. K., GELLER, E. B., ADLER, M. W. AND ROGERS, T. J.: Immunomodulatory activity of mu and kappa-selective opioid agonists. Proc. Nat. Acad. Sci. 22: 360-364, 1991.
48. WATSON, R. R., PRABHALA, R. H., DARBAN, H. R., YAHYA, M. D. AND SMITH T. L.: Changes in lymphocyte and macrophage subsets due to mrophine and ethanol treatment during a retrovirus infection causing murine aids. Immunopharmacology 43: 1-11, 1988.
49. WEBER, R. J. AND PERT, A.: The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245: 188-190, 1989.
50. WEBER, R. J. AND PERT, C. B.: Opiatergic modulation of the immune system. In: Central and Peripheral Endorphins: Basic and Clinical Aspects, ed. by E. E. Muller and A. R. Genazzani, pp. 35-41, Raven Press, New York, 1984.
51. WEBER, R. J., IKEJIRI, B., RICE, K. C., PERT, A. AND HAGAN, A. A.: Opiate receptor mediated regulation of the immune response in vivo. In Problems of Drug Dependence, ed. by Harris, L. S., NIDA Res. Monogr. 76: 341-348, 1987.
52. WILLIAMS, J. H., PETERSON, R. G., SHEA, P. A., SCHMEDTJE, J. F., BAUER, D. C. AND FELTEN, D. L.: Sympathetic innervation of murine thymus and spleen: Evidence for a functional link between the nervous and immune systems. Brain Res. Bull. 6: 83-94, 1981.
53. WYBRAN, J., APPELBOOM, T., FAMACY, J. P. AND GOVAERTS, A.: Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T-lymphocytes. J. Immunol. 123: 1068-1070, 1979.
54. YAHYA, M. D. AND WATSON, R. R.: Immunomodulation by morphine and marijuana. Life Sci. 41: 2503-2510, 1987.